Explore our sister journals here.

Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 16.08.13 in Vol 15, No 8 (2013): August

This paper is in the following e-collection/theme issue:

Works citing "Crowdsourcing Black Market Prices For Prescription Opioids"

Nabarun Dasgupta, Clark Freifeld, John S Brownstein, Christopher Mark Menone, Hilary L Surratt, Luke Poppish, Jody L Green, Eric J Lavonas, Richard C Dart

J Med Internet Res 2013 (Aug 16); 15(8):e178 

According to Crossref, the following articles are citing this article (DOI 10.2196/jmir.2810):

(note that this is only a small subset of citations)

  1. Katsuki T, Mackey TK, Cuomo R. Establishing a Link Between Prescription Drug Abuse and Illicit Online Pharmacies: Analysis of Twitter Data. Journal of Medical Internet Research 2015;17(12):e280
    CrossRef
  2. Créquit P, Mansouri G, Benchoufi M, Vivot A, Ravaud P. Mapping of Crowdsourcing in Health: Systematic Review. Journal of Medical Internet Research 2018;20(5):e187
    CrossRef
  3. Schwab-Reese LM, Hovdestad W, Tonmyr L, Fluke J. The potential use of social media and other internet-related data and communications for child maltreatment surveillance and epidemiological research: Scoping review and recommendations. Child Abuse & Neglect 2018;85:187
    CrossRef
  4. . Buprenorphine for opioid dependence. Mental Health Clinician 2013;3(6):286
    CrossRef
  5. Hill R, Santhakumar R, Dewey W, Kelly E, Henderson G. Fentanyl depression of respiration: Comparison with heroin and morphine. British Journal of Pharmacology 2020;177(2):254
    CrossRef
  6. . Endogenous opiates and behavior: 2013. Peptides 2014;62:67
    CrossRef
  7. Homer J, Wakeland W. A dynamic model of the opioid drug epidemic with implications for policy. The American Journal of Drug and Alcohol Abuse 2021;47(1):5
    CrossRef
  8. Iwanicki JL, Severtson SG, McDaniel H, Rosenblum A, Fong C, Cicero TJ, Ellis MS, Kurtz SP, Buttram ME, Dart RC, Landau R. Abuse and Diversion of Immediate Release Opioid Analgesics as Compared to Extended Release Formulations in the United States. PLOS ONE 2016;11(12):e0167499
    CrossRef
  9. Pashmineh Azar AR, Cruz‐Mullane A, Podd JC, Lam WS, Kaleem SH, Lockard LB, Mandel MR, Chung DY, Simoyan OM, Davis CS, Nichols SD, McCall KL, Piper BJ. Rise and regional disparities in buprenorphine utilization in the United States. Pharmacoepidemiology and Drug Safety 2020;29(6):708
    CrossRef
  10. Minhas M, Leri F. A Multifaceted Analysis of Oxycodone Addiction. International Journal of Mental Health and Addiction 2018;16(4):1016
    CrossRef
  11. Wiegand TJ, Le Lait M, Bartelson BB, Dart RC, Green JL. Analysis of the Abuse and Diversion of the Buprenorphine Transdermal Delivery System. The Journal of Pain 2016;17(6):745
    CrossRef
  12. Lebin JA, Murphy DL, Severtson SG, Bau GE, Dasgupta N, Dart RC. Scoring the best deal: Quantity discounts and street price variation of diverted oxycodone and oxymorphone. Pharmacoepidemiology and Drug Safety 2019;28(1):25
    CrossRef
  13. Fan M, Tscheng D, Hamilton M, Trbovich P. Opioid losses in terms of dosage and value, January 2012 to September 2017: a retrospective analysis of Health Canada data. CMAJ Open 2020;8(1):E113
    CrossRef
  14. . The Potential of Crowdsourcing to Improve Patient-Centered Care. The Patient - Patient-Centered Outcomes Research 2014;7(2):123
    CrossRef
  15. Horyniak D, Agius PA, Degenhardt L, Reddel S, Higgs P, Aitken C, Stoové M, Dietze P. Patterns of, and Factors Associated With, Illicit Pharmaceutical Opioid Analgesic Use in a Prospective Cohort of People Who Inject Drugs in Melbourne, Australia. Substance Use & Misuse 2015;50(13):1650
    CrossRef
  16. DePriest AZ, Heltsley R, Black DL, Mitchell JM, LoDico C, Flegel R, Cone EJ. Prescription Opioids. V. Metabolism and Excretion of Oxymorphone in Urine Following Controlled Single Dose Administration. Journal of Analytical Toxicology 2016;40(8):566
    CrossRef
  17. Hulme S, Bright D, Nielsen S. The source and diversion of pharmaceutical drugs for non-medical use: A systematic review and meta-analysis. Drug and Alcohol Dependence 2018;186:242
    CrossRef
  18. Dart RC, Surratt HL, Le Lait M, Stivers Y, Bebarta VS, Freifeld CC, Brownstein JS, Burke JJ, Kurtz SP, Dasgupta N. Diversion and Illicit Sale of Extended Release Tapentadol in the United States. Pain Medicine 2016;17(8):1490
    CrossRef
  19. Vosburg SK, Severtson SG, Dart RC, Cicero TJ, Kurtz SP, Parrino MW, Green JL. Assessment of Tapentadol API Abuse Liability With the Researched Abuse, Diversion and Addiction-Related Surveillance System. The Journal of Pain 2018;19(4):439
    CrossRef
  20. Barratt MJ, Ferris JA, Winstock AR. Use of Silk Road, the online drug marketplace, in the United Kingdom, Australia and the United States. Addiction 2014;109(5):774
    CrossRef
  21. Brady CJ, Villanti AC, Pearson JL, Kirchner TR, Gupta OP, Shah CP. Rapid Grading of Fundus Photographs for Diabetic Retinopathy Using Crowdsourcing. Journal of Medical Internet Research 2014;16(10):e233
    CrossRef
  22. Hswen Y, Zhang A, Brownstein JS. Leveraging black-market street buprenorphine pricing to increase capacity to treat opioid addiction, 2010–2018. Preventive Medicine 2020;137:106105
    CrossRef
  23. . Applications of crowdsourcing in health: an overview. Journal of Global Health 2018;8(1)
    CrossRef
  24. Oesterle TS, Thusius NJ, Rummans TA, Gold MS. Medication-Assisted Treatment for Opioid-Use Disorder. Mayo Clinic Proceedings 2019;94(10):2072
    CrossRef
  25. Corazza O, Valeriani G, Bersani FS, Corkery J, Martinotti G, Bersani G, Schifano F. “Spice,” “Kryptonite,” “Black Mamba”: An Overview of Brand Names and Marketing Strategies of Novel Psychoactive Substances on the Web. Journal of Psychoactive Drugs 2014;46(4):287
    CrossRef
  26. Kazemi DM, Borsari B, Levine MJ, Dooley B. Systematic review of surveillance by social media platforms for illicit drug use. Journal of Public Health 2017;39(4):763
    CrossRef
  27. Simpson KJ, Moran MT, McCall KL, Herbert J, Foster ML, Simoyan OM, Shah DT, Desrosiers C, Nichols SD, Piper BJ. Increasing heroin, cocaine, and buprenorphine arrests reported to the Maine Diversion Alert Program. Forensic Science International 2019;303:109924
    CrossRef
  28. Schmidt TD, Haddox JD, Nielsen AE, Wakeland W, Fitzgerald J. Key Data Gaps Regarding the Public Health Issues Associated with Opioid Analgesics. The Journal of Behavioral Health Services & Research 2015;42(4):540
    CrossRef
  29. Brown R, Riley MR, Ulrich L, Kraly EP, Jenkins P, Krupa NL, Gadomski A. Impact of New York prescription drug monitoring program, I-STOP, on statewide overdose morbidity. Drug and Alcohol Dependence 2017;178:348
    CrossRef
  30. Van Hout MC, Bingham T. Responsible vendors, intelligent consumers: Silk Road, the online revolution in drug trading. International Journal of Drug Policy 2014;25(2):183
    CrossRef
  31. Cummings OT, Morris AA, Enders JR, McIntire GL. Normalizing Oral Fluid Hydrocodone Data Using Calculated Blood Volume. Journal of Analytical Toxicology 2016;40(7):486
    CrossRef
  32. Li J, Xu Q, Shah N, Mackey TK. A Machine Learning Approach for the Detection and Characterization of Illicit Drug Dealers on Instagram: Model Evaluation Study. Journal of Medical Internet Research 2019;21(6):e13803
    CrossRef
  33. Kingsley SC, Gray ML, Suri S. Accounting for Market Frictions and Power Asymmetries in Online Labor Markets. Policy & Internet 2015;7(4):383
    CrossRef
  34. Geoffrey Severtson S, Kreider SED, Amioka EC, Margolin ZR, Iwanicki JL, Dart RC. Postmarketing Analysis of Misuse, Abuse, and Diversion of Xtampza ER. Pain Medicine 2020;21(12):3660
    CrossRef
  35. Dave D, Deza M, Horn B. Prescription drug monitoring programs, opioid abuse, and crime. Southern Economic Journal 2021;87(3):808
    CrossRef
  36. Li Z, Du X, Liao X, Jiang X, Champagne-Langabeer T. Demystifying the Dark Web Opioid Trade: Content Analysis on Anonymous Market Listings and Forum Posts. Journal of Medical Internet Research 2021;23(2):e24486
    CrossRef
  37. Yanuck J, Lee JB, Saadat S, Rouhi J, Ghanem G, Chakravarthy B, Shah S, Enax-Krumova EK. Opioid Prescription Patterns for Discharged Patients from the Emergency Department. Pain Research and Management 2021;2021:1
    CrossRef
  38. Connors NJ, Mazer-Amirshahi M, Motov S, Kim HK. Relative addictive potential of opioid analgesic agents. Pain Management 2021;11(2):201
    CrossRef
  39. Babalonis S, Comer SD, Jones JD, Nuzzo P, Lofwall MR, Manubay J, Hatton KW, Whittington RA, Walsh SL. Relative potency of intravenous oxymorphone compared to other µ opioid agonists in humans — pilot study outcomes. Psychopharmacology 2021;238(9):2503
    CrossRef
  40. Shah N, Li J, Mackey TK. An Unsupervised Machine Learning Approach for the Detection and Characterization of Illicit Drug-Dealing Comments and Interactions on Instagram. Substance Abuse 2022;43(1):273
    CrossRef
  41. Black J, Margolin ZR, Bau G, Olson R, Iwanicki JL, Dart RC. Web-Based Discussion and Illicit Street Sales of Tapentadol and Oxycodone in Australia: Epidemiological Surveillance Study. JMIR Public Health and Surveillance 2021;7(12):e29187
    CrossRef
  42. Mutter R, Black J, Iwanicki J. Changes in the Street Prices of Prescription Opioids During the COVID-19 Pandemic. Psychiatric Services 2023;74(1):63
    CrossRef
  43. Scheibein F, Donnelly W, Wells JS. Assessing open science and citizen science in addictions and substance use research: A scoping review. International Journal of Drug Policy 2022;100:103505
    CrossRef
  44. Hu C, Liu B, Ye Y, Li X. Fine-grained classification of drug trafficking based on Instagram hashtags. Decision Support Systems 2023;165:113896
    CrossRef
  45. Kaufman DE, Kennalley AL, McCall KL, Piper BJ. Examination of methadone involved overdoses during the COVID-19 pandemic. Forensic Science International 2023;344:111579
    CrossRef
  46. Hayes CJ, Goree J, Turpin J, Ortiz H, Smith GR, Gokarakonda SB, Hyde C, Cucciare MA. Leveraging the Prescription Drug Monitoring Program to Curb Opioid Prescribing in Arkansas. Journal of Prevention 2022;43(3):337
    CrossRef
  47. Haupt MR, Cuomo R, Li J, Nali M, Mackey TK. The influence of social media affordances on drug dealer posting behavior across multiple social networking sites (SNS). Computers in Human Behavior Reports 2022;8:100235
    CrossRef
  48. Roe SA, DeSalve DS, Piper BJ. Analyzing Black Market Sales of the Second-Line ADHD Medication Atomoxetine. Pharmacoepidemiology 2023;2(4):320
    CrossRef
  49. Pande LJ, Arnet RE, Piper BJ. An Examination of the Complex Pharmacological Properties of the Non-Selective Opioid Modulator Buprenorphine. Pharmaceuticals 2023;16(10):1397
    CrossRef
  50. Wagner KD, Fiuty P, Page K, Tracy EC, Nocera M, Miller CW, Tarhuni LJ, Dasgupta N. Prevalence of fentanyl in methamphetamine and cocaine samples collected by community-based drug checking services. Drug and Alcohol Dependence 2023;252:110985
    CrossRef
  51. Sudan HK, Tai AMY, Kim J, Krausz RM. Decrypting the cryptomarkets: Trends over a decade of the Dark Web drug trade. Drug Science, Policy and Law 2023;9
    CrossRef
  52. . A Perspective on Crowdsourcing and Human-in-the-Loop Workflows in Precision Health. Journal of Medical Internet Research 2024;26:e51138
    CrossRef
  53. . Disrupting Drug Markets: The Effects of Crackdowns on Rogue Opioid Suppliers. SSRN Electronic Journal 2023;
    CrossRef

According to Crossref, the following books are citing this article (DOI 10.2196/jmir.2810):

  1. Sevigny EL, Fuleihan B. The Handbook of Drugs and Society. 2015. :258
    CrossRef
  2. Cao M, Zhang J, Xu S, Ying Z. Cloud Computing. 2021. Chapter 1:3
    CrossRef
  3. Jordan A, Martinez CP, Isom J. Treating Opioid Use Disorder in General Medical Settings. 2021. Chapter 13:189
    CrossRef